Insulin Aspart drug substance

Biocon Biologics to supply insulin Aspart drug substance to Civica for US market

Biocon Biologics Ltd, a fully integrated global biosimilars company and a subsidiary of Biocon, has announced a collaboration with Civica,…

6 hours ago